Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: Sotrovimab retains its activity vs Omicron variant
Investegate announcements from GlaxoSmithKline PLC, Sotrovimab retains its activity vs Omicron variant
Stay updated with breaking news from Jeff Mclaughlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from GlaxoSmithKline PLC, Sotrovimab retains its activity vs Omicron variant
– New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published... | December 7, 2021
07.12.2021 - – New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published last week, underscoring the importance of sotrovimab for early treatment of ...
Investegate announcements from GlaxoSmithKline PLC, Medicago/GSK COVID-19 vaccine positive Ph3 data
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3%